Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Dominant negative OTULIN Related Autoinflammatory Syndrome

View ORCID ProfileSophia Davidson, View ORCID ProfileYuri Shibata, Sophie Collard, Pawat Laohamonthonku, Klara Kong, June Sun, CIRCA, AADRY, Margaret W.Y. Li, Carolyn Russell, Anna van Beek, Edwin P. Kirk, Rebecca Walsh, View ORCID ProfilePaul E. Gray, View ORCID ProfileDavid Komander, View ORCID ProfileSeth L. Masters
doi: https://doi.org/10.1101/2023.03.24.23287549
Sophia Davidson
1Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sophia Davidson
  • For correspondence: davidson.s{at}wehi.edu.au
Yuri Shibata
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
3Ubiquitin Signaling Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yuri Shibata
Sophie Collard
1Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pawat Laohamonthonku
1Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klara Kong
1Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June Sun
1Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret W.Y. Li
4School of Medicine, University of New South Wales, Sydney, Australia
5Department of immunology and infectious diseases, Sydney children’s hospital,Randwick, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Russell
6Department of Paediatric Surgery, Sydney Children’s Hospital,Randwick, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna van Beek
7Department of General Paediatrics, Sydney Children’s Hospital, Randwick, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin P. Kirk
4School of Medicine, University of New South Wales, Sydney, Australia
8Department of Medical Genetics, Sydney Children’s Hospital,Randwick, Sydney, Australia
9NSW Health Pathology Genetic Laboratory, Randwick, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Walsh
9NSW Health Pathology Genetic Laboratory, Randwick, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul E. Gray
5Department of immunology and infectious diseases, Sydney children’s hospital,Randwick, Sydney, Australia
10University of Western Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul E. Gray
David Komander
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
3Ubiquitin Signaling Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Komander
Seth L. Masters
1Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia
2Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seth L. Masters
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Biallelic loss of function mutations in the linear chain specific deubiquitinase (DUB) OTULIN (OTU Deubiquitinase With Linear Linkage Specificity) result in OTULIN Related Autoinflammatory Syndrome (ORAS). To date all reported ORAS patients have had homozygous or compound heterozygous loss of function mutations, however we identified a patient with a monoallelic heterozygous mutation p.Cys129Ser. Consistent with the ORAS phenotype, we observed accumulation of linear ubiquitin chains, increased sensitivity to TNF induced cell death and dysregulation of inflammatory signalling in both patient cells and in vitro exogenous expression models. Levels of the mutant OTULIN protein were consistent with wild type OTULIN in patient cells and exogenous expression systems and maintained binding capacity to both LUBAC and linear ubiquitin chains. However, even in a heterozygous context this mutant DUB promoted the global accumulation of linear ubiquitin chains. Furthermore, it allowed accumulation of ubiquitin on the linear ubiquitin chain assembly complex (LUBAC). Altered ubiquitination of LUBAC leads to a dysregulation of NF-κB signalling and promotion of TNF induced cell death. By reporting the first dominant negative mutation driving ORAS this study expands our clinical understanding of Otulin mediated pathology.

Summary The dominant negative mutation OTULIN:p.Cys129Ser is sufficient to drive ORAS. Mutant OTULIN outcompetes wildtype for interaction with SHARPIN, this increases M1-ubiquitination of LUBAC and other targets, thereby promoting cell death and consequent inflammatory signalling.

Competing Interest Statement

SLM is a Scientific Advisor for NRG Therapeutics and Odyssey Therapeutics. DK is founder and shareholder of Entact Bio.

Funding Statement

This work was supported by grants from the Australian National Health and Medical Research Council (2003159, 2003756; S.L.M.), fellowships from the Victorian Endowment for Science Knowledge and Innovation (S.L.M.), the HHMI-Wellcome International Research Scholarship (S.L.M.) and the Sylvia and Charles Viertel Foundation (S.L.M.). S.D. acknowledges funding from NHMRC grants (GNT1143412 and GNT2003756).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRBs of Sydney Childrens Hospital, National Institutes of Health (NIH) and Walter and Eliza Hall Institute (WEHI), gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 27, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Dominant negative OTULIN Related Autoinflammatory Syndrome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Dominant negative OTULIN Related Autoinflammatory Syndrome
Sophia Davidson, Yuri Shibata, Sophie Collard, Pawat Laohamonthonku, Klara Kong, June Sun, CIRCA, AADRY, Margaret W.Y. Li, Carolyn Russell, Anna van Beek, Edwin P. Kirk, Rebecca Walsh, Paul E. Gray, David Komander, Seth L. Masters
medRxiv 2023.03.24.23287549; doi: https://doi.org/10.1101/2023.03.24.23287549
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Dominant negative OTULIN Related Autoinflammatory Syndrome
Sophia Davidson, Yuri Shibata, Sophie Collard, Pawat Laohamonthonku, Klara Kong, June Sun, CIRCA, AADRY, Margaret W.Y. Li, Carolyn Russell, Anna van Beek, Edwin P. Kirk, Rebecca Walsh, Paul E. Gray, David Komander, Seth L. Masters
medRxiv 2023.03.24.23287549; doi: https://doi.org/10.1101/2023.03.24.23287549

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)